The policy debate about drug reimportation brings up a lot of interesting questions, touching on the topics of free trade, price discrimination, and protection of intellectual property rights.
Princeton economist Uwe Reinhardt has a good discussion of some of the issues. For an old post of mine,
click here.
0 Comments